Transfusion Medicine

A stable patient three weeks into leukemia induction needs a routine lumbar puncture with platelets below the guideline threshold — and a treatment course ahead of him that makes every transfusion decision from here on a cumulative one, not an isolated one.

Two days after an endoscopically treated ulcer, a modest overnight hemoglobin drift runs into a real disagreement about whether stable coronary artery disease changes the transfusion math — and whether the trial evidence behind the restrictive threshold actually speaks to his specific anatomy.

A motorcycle collision brings a patient into the trauma bay in real hemorrhagic shock before any laboratory value can return — and the massive transfusion protocol's own internal ratio becomes the actual, unresolved question.

A patient's informed, standing refusal of blood transfusion meets a hemoglobin that is still falling despite endoscopic hemostasis — and a team weighing what pharmacology can honestly offer against how much time it actually has.

A new mother's fibrinogen has collapsed well below her own pregnancy baseline during ongoing postpartum hemorrhage — and the team disagrees over whether the faster-reconstituting, off-label product or the slower, on-label one should go in first.

A patient with three documented red cell alloantibodies is desaturating in real time from acute chest syndrome — and the team must decide how much matching completeness a genuinely deteriorating patient can actually afford to wait for.

A young man is bleeding briskly mid-appendectomy with a documented history of anaphylaxis to blood transfusion — and the team must decide whether premedication is an acceptable stopgap or whether washing is the only real answer, on a clock that doesn't wait for either.

A young woman beginning years of monthly transfusion after her first stroke sits at the actual point a guideline's conditional recommendation was written for — and the team must decide how much of it this blood bank can really promise.